About the show
Trusted answers about GLP-1 medications, weight loss and more
The Plus SideZ is a weekly podcast about GLP-1 medications, obesity treatment and metabolic health, hosted by Kim Carlos and Kat Carter. It began with an online community of people who had been prescribed a GLP-1 and given almost no guidance about what came next.
Guests include doctors, obesity medicine specialists, endocrinologists, researchers, bariatric surgeons and policy experts explaining what the evidence actually says, alongside patients describing what treatment is like in practice: the side effects, the insurance denials, the plateaus, and the parts nobody warned them about.
Episodes are recorded in Atlanta and published weekly wherever you listen, with a video version on YouTube. Every episode is free.
What we cover
The questions that come up again and again
The medications
Ozempic, Wegovy, Mounjaro, Zepbound and the new oral options like Foundayo, how they differ, what the trials found, compounded versions, and what is coming next.
Side effects and dosing
Nausea, muscle loss, plateaus and stalls, titration, maintenance, and what to raise with your practitioner.
Cost and coverage
Insurance denials and appeals, Medicare and Medicaid, employer plans, drug pricing, and the policy fights behind them.
The science of obesity
Obesity as a chronic disease, food noise, hormones, PCOS and metabolic health, and where the research is heading.
Living with it
Stigma and bias, relationships, protein and fitness, regain, and the emotional side nobody prepares you for.
Patient stories
People at every stage, from deciding whether to start through years into maintenance, telling it how it actually went.
Browse every episode in the full library, searchable by topic and guest.
Recognition
Awards and press
The show has been recognized with two Anthem Awards for social impact, American Writing Awards Podcast of the Year, and a Communicator Awards Award of Distinction. Kim's advocacy on drug pricing has been covered by Good Morning America, Bloomberg News and ABC Nightline, and she contributed to Health magazine's guide to understanding GLP-1s.
As seen in
Each logo links to the coverage.
Common questions
Before you press play
Who is this podcast for?
Anyone taking a GLP-1, considering one, or supporting someone who is. Clinicians and researchers listen too, but every episode is made to be understood without a medical background.
Where can I listen?
On Spotify, Apple Podcasts, YouTube, or in the player on our episodes page.
How often do new episodes come out?
Weekly, with occasional bonus episodes when news breaks on pricing, coverage or a new medication.
Is this medical advice?
No. The show is education and lived experience. Decisions about your treatment belong with you and your practitioner.
Can I be a guest, or pitch a topic?
Yes. Clinicians, researchers and patients are all welcome to get in touch.
Meet the hosts
Two advocates who started where you are
Kim Carlos
Obesity care advocate, founder, host, executive producer
In 2022, Kim got a GLP-1 prescription and almost no guidance, so she went to TikTok and found a few hundred people doing the same thing. That community grew into tens of thousands, then into this podcast. She works on medication access and drug pricing, and her advocacy has been covered by Good Morning America, Bloomberg News and ABC Nightline.
More about KimKat Carter
Co-host, co-producer, obesity care advocate
Kat co-hosts and produces the show, bringing community stories to the front and most of the fun. She is a fitness at any size advocate and a Prince and wine enthusiast.